1 week Ago By Defense World Staff
Equities research analysts at StockNews.com assumed coverage on shares of Mannatech ( NASDAQ:MTEX – Get Free Report ) in a note issued to investors on Sunday. The brokerage set a “buy” rating on the stock.
Mannatech Stock Down 1.1 % MTEX opened at $14.73 on Friday.
Mannatech has a 52 week low of $6.75 and a 52 week high of $15.25.
The business has a 50 day moving average price of $9.92 and a two-hundred day moving average price of $8.26.
The company has a quick ratio of 0.74, a current ratio of 1.25 and a debt-to-equity ratio of 0.
44. The company has a market cap of $27.77 million, a PE ratio of -18.
18 and a beta of 1.04. Mannatech ( NASDAQ:MTEX – Get Free Report ) last released its quarterly earnings results on Tuesday, November 12th.
The company reported ($0.17) EPS for the quarter. Mannatech had a negative return on equity of 15.
62% and a negative net margin of 1.26%. The company had revenue of $31.
73 million for the quarter. Mannatech Company Profile Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products.
It primarily sells its products directly, as well as through e-commerce and network marketing channels. Read More Five stocks we like better than Mannatech What is the Shanghai Stock Exchange Composite Index? Quantum Opportunity: Skywater Technology’s Long-Term Potential Industrial Products Stocks Investing Nebius Group: The Rising Star in AI Infrastructure How Investors Can Identify and Successfully Trade Gap-Down Stocks MarketBeat Week in Review – 12/30 – 1/03 Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter .
.
